Responses
Clinical/translational cancer immunotherapy
Original research
Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.